Topical Therapies for the Treatment of Atopic Dermatitis: Balancing Safety, Efficacy, and Access : Episode 2
Opinion
Video
Atopic Dermatitis: Topical Therapies and Unmet Needs in the Treatment Landscape
Key opinion leaders provide a concise overview of the atopic dermatitis (AD) treatment landscape, focusing on the role of topical therapy, and highlight the current unmet needs in AD management.
- Provide a brief overview of the treatment landscape, and where topical therapies and systemic therapies fit into this landscape. What are the current unmet needs from your perspective?
- Please incorporate a discussion of the following topical therapies:
- Corticosteroids
- Crisaborole – AD-301/AD-302, CrisADe CARE 1
- Ruxolitinib – TRuE-AD1/TRuE-AD2 – original publication, long-term follow up
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Videos
Related Content
